References
- Stone R M, O'Donnell M R, Sekeres M A. Acute myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 2004; 98–117
- Ries L, Eisner M, Kosary C, et al. SEER. Cancer Statistics Review 1975 – 2001, National Cancer Institute. National Cancer Institute, Bethesda, MD 2004
- Tallman M S, Gilliland D G, Rowe J M. Drug therapy of acute myeloid leukemia. Blood 2005; 106: 1154–1163
- Tallman M. Differentiation therapy in acute myeloid leukemia. Leukemia 1996; 10: 1262–1268
- Benette J M, Catovsky D, Daniel M T, et al. Proposed revised criteria for the classification of acute myelogenous leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620–625
- Jantunen E, Mahlamäki E, Heinonen K, Nousiainen T. Multiple complete remissions in a patient with acute myeloid leukemia (M4eo) with low-dose cytosine arabinoside and all-trans retinoic acid. Leuk Lymphoma 2003; 44: 883–885
- Ferrara F, Palmieri S, Mele G. Prognostic factors and theurapeutic options for relapsed or refractory acute myeloid leukemia. Haematologica 2004; 89: 998–1008
- Wählin A, Markevärn B, Golovleva I, Nilson M. Prognostic significance of risk group stratification in elderly patients with acute myeloid leukemia. Br J Hematol 2001; 115: 25–33
- Deeg H J, Shulman H M, Anderson J E, Boyant E M, Gooley T A, Slattery J T, et al. Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 – 66 years of age. Blood 2000; 95: 1088–1194
- Anderlini P, Ghaddar H M, Smith T L, Pievre S, Kantarjian H M, O'Brien S, et al. Factors predicting complete remission and subsequisitive disease-free-survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first. Leukemia 1996; 10: 964–969
- Isnard F, Guiguet M, Laporte J P, Zunic P, Elloumi M, Cheron N, et al. Improved efficiency of remission induction facillitates autologous BMT harvesting and improves overall survival in adults with AML: 108 patients treated at a single institution. Bone Marrow Transplant 2001; 27: 1045–1052
- Kusnierz-Glaz C R, Schlegel P G, Wong R M, Schriber J R, Chao N J, Anylon M D, et al. Influence of age and the outcome of 500 autologous bone marrow transplant procedures for haematological procedures. J Clin Oncol 1997; 15: 18–25
- Breems D A, Van Putten W L, Huijgens P C, Ossenkoppeke G J, Verhoef G E, Verdonck L F, et al. Prognostic Index for adults with acute myeloid leukemia in first relapse. J Clin Oncol 2005; 23: 1969–1978
- Arlin Z A, Feldman E J, Figer L, Ahmed T, Mittelman A, Ruccio C, et al. Quality remissions: a new target of induction therapy in acute leukaemia and the next step in developing curative treatments. Semin Hematol 1991; 28: 44–47
- Leopold L H, Willemre R. The treatment of AML in first relapse: a comprehensive review of the literature. Leuk Lymphoma 2002; 43: 1715–1727